4 results
Approved WMOCompleted
see protocol summary
Not approvedWill not start
The primary objective of the study is to descriptively characterize the single-dose and steadystatePharmacokinetics (PK) of diacerein (if quantifiable) and its active metabolite, rhein, after topical application of CCP-020 (diacerein 1% ointment)…
Approved WMOCompleted
The primary objective of this study is to evaluate the long-term safety and tolerability of Diacerein 1% Ointment for 2 treatment cycles in subjects with EBS that were previously enrolled in studies CCP-020-301 or CCP-020-101.
Approved WMOCompleted
Find/confirm percentage of remission after discontinuing TPO-RA in persistent and chronic ITP patients.